Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Biohaven Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 297
- +22 vs. Q1 2026
- Shares held
- 143.5M
- +16.7M (+13.2%) vs. Q1 2026
- Total value
- $2.13B
- +$1.06B (+99.0%) vs. Q1 2026
- New holders
- 53
- 110 more added
- Sold out
- 31
- 87 more reduced
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.22B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.28B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.24B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.34B |
| Q2 2024 | 228 | $2.90B |
| Q1 2024 | 245 | $4.09B |
| Q4 2023 | 220 | $3.09B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 180 | $921.1M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.26B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.58B |
| Q4 2021 | 284 | $8.55B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 109,161 | $1.62M | 0.00% | −68,517−38.6% | Reduced |
| Mercer Global Advisors Inc | 114,594 | $1.71M | 0.00% | +65,369+132.8% | Added |
| Wealth Enhancement Advisory Services, LLC | 125,152 | $1.73M | 0.00% | +64,135+105.1% | Added |
| Creative Planning | 118,599 | $1.76M | 0.00% | +62,486+111.4% | Added |
| DCF Advisers, LLC | 130,000 | $1.93M | 0.51% | +6,500+5.3% | Added |
| Barclays PLC | 132,959 | $1.98M | 0.00% | +7,137+5.7% | Added |
| DAFNA Capital Management LLC | 137,593 | $2.05M | 0.39% | −708,142−83.7% | Reduced |
| Caption Management, LLC | 145,000 | $2.16M | 0.08% | +69,661+92.5% | Added |
| Renaissance Technologies LLC | 150,752 | $2.24M | 0.00% | −10,200−6.3% | Reduced |
| Empowered Funds, LLC | 152,060 | $2.26M | 0.01% | +3,304+2.2% | Added |
| Manufacturers Life Insurance Company, The | 159,067 | $2.37M | 0.00% | −43,908−21.6% | Reduced |
| TD Asset Management Inc | 160,190 | $2.38M | 0.00% | −17,200−9.7% | Reduced |
| Cerity Partners LLC | 161,910 | $2.41M | 0.00% | +49,085+43.5% | Added |
| Sphera Funds Management Ltd. | 164,437 | $2.45M | 0.35% | −429,563−72.3% | Reduced |
| Rhumbline Advisers | 164,749 | $2.45M | 0.00% | +27,866+20.4% | Added |
| California State Teachers Retirement System | 168,876 | $2.51M | 0.00% | −3,494−2.0% | Reduced |
| XTX Topco Ltd | 170,163 | $2.53M | 0.03% | −238,319−58.3% | Reduced |
| Wells Fargo & Company | 170,270 | $2.53M | 0.00% | +77,229+83.0% | Added |
| Quantinno Capital Management LP | 170,749 | $2.54M | 0.00% | +49,195+40.5% | Added |
| New York State Common Retirement Fund | 180,651 | $2.69M | 0.00% | +20,400+12.7% | Added |
| Susquehanna International Group, LLP | 181,182 | $2.70M | 0.00% | −124,385−40.7% | Reduced |
| Deutsche Bank AG | 201,499 | $3.00M | 0.00% | +38,686+23.8% | Added |
| Federated Hermes, Inc. | 202,040 | $3.01M | 0.00% | +202,040 | New |
| Mariner, LLC | 212,539 | $3.16M | 0.00% | +117,163+122.8% | Added |
| Boothbay Fund Management, LLC | 230,684 | $3.43M | 0.07% | +102,822+80.4% | Added |
| Jane Street Group, LLC | 238,403 | $3.55M | 0.00% | +9,959+4.4% | Added |
| NewEdge Wealth, LLC | 245,670 | $3.66M | 0.04% | −833−0.3% | Reduced |
| Swiss National Bank | 249,000 | $3.71M | 0.00% | −9,600−3.7% | Reduced |
| Affinity Asset Advisors, LLC | 250,000 | $3.72M | 0.18% | +250,000 | New |
| Ameriprise Financial Inc | 268,227 | $3.99M | 0.00% | +212,887+384.7% | Added |
| HRT Financial LP | 268,529 | $4.00M | 0.01% | −565,137−67.8% | Reduced |
| Susquehanna Portfolio Strategies, LLC | 269,967 | $4.02M | 0.06% | −40,680−13.1% | Reduced |
| Royal Bank of Canada | 290,401 | $4.32M | 0.00% | +167,949+137.2% | Added |
| Algert Global LLC | 308,980 | $4.60M | 0.05% | −13,770−4.3% | Reduced |
| Invesco Ltd. | 309,068 | $4.60M | 0.00% | +56,137+22.2% | Added |
| Citigroup Inc | 314,453 | $4.68M | 0.00% | +279,216+792.4% | Added |
| QTR Family Wealth, LLC | 337,432 | $5.02M | 1.75% | +1,452+0.4% | Added |
| QVT Financial LP | 354,206 | $5.27M | 0.34% | +184,200+108.3% | Added |
| Standard Life Aberdeen plc | 365,519 | $5.44M | 0.01% | −405,933−52.6% | Reduced |
| Bank of New York Mellon Corp | 386,939 | $5.76M | 0.00% | +79,695+25.9% | Added |
| Millennium Management LLC | 417,534 | $6.21M | 0.00% | −1,030,352−71.2% | Reduced |
| Two Sigma Investments, LP | 443,775 | $6.60M | 0.00% | −742,939−62.6% | Reduced |
| Fiera Capital Corp | 445,769 | $6.63M | 0.02% | −328,399−42.4% | Reduced |
| Raymond James Financial Inc | 465,895 | $6.93M | 0.00% | +19,284+4.3% | Added |
| Ieq Capital, LLC | 475,865 | $7.08M | 0.03% | +197,161+70.7% | Added |
| JPMorgan Chase & Co | 469,832 | $7.11M | 0.00% | −33,733−6.7% | Reduced |
| Point72 Asset Management, L.P. | 491,918 | $7.32M | 0.01% | +118,819+31.8% | Added |
| Burkehill Global Management, LP | 500,000 | $7.44M | 0.27% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 501,687 | $7.47M | 0.35% | +456,910+1,020.4% | Added |
| Trexquant Investment LP | 503,694 | $7.49M | 0.05% | −374,080−42.6% | Reduced |
| Eversept Partners, LP | 515,804 | $7.68M | 0.42% | +515,804 | New |
| Pfizer Inc | 505,645 | $8.00M | 4.70% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 582,312 | $8.66M | 4.87% | +19,128+3.4% | Added |
| Longaeva Partners L.P. | 599,903 | $8.93M | 0.26% | +599,903 | New |
| Marshall Wace, LLP | 651,349 | $9.69M | 0.01% | +298,744+84.7% | Added |
| Integral Health Asset Management, LLC | 700,000 | $10.4M | 0.43% | −300,000−30.0% | Reduced |
| 5AM Venture Management, LLC | 738,972 | $11.0M | 3.82% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 737,300 | $11.0M | 0.09% | +44,000+6.3% | Added |
| Ikarian Capital, LLC | 748,181 | $11.1M | 1.82% | +335,700+81.4% | Added |
| Vanguard Fiduciary Trust Co | 828,779 | $12.3M | 0.00% | +127,188+18.1% | Added |
| Morgan Stanley | 841,351 | $12.5M | 0.00% | −185,581−18.1% | Reduced |
| Voloridge Investment Management, LLC | 882,724 | $13.1M | 0.06% | −337,106−27.6% | Reduced |
| Qube Research & Technologies Ltd | 905,935 | $13.5M | 0.01% | −634,510−41.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $14.9M | 0.02% | −497,793−33.2% | Reduced |
| Simplify Asset Management Inc. | 1,040,255 | $15.5M | 0.22% | +141,855+15.8% | Added |
| StemPoint Capital LP | 1,064,200 | $15.8M | 2.74% | −530,291−33.3% | Reduced |
| Charles Schwab Investment Management Inc | 1,109,283 | $16.5M | 0.00% | +168,206+17.9% | Added |
| MYDA Advisors LLC | 1,150,000 | $17.1M | 4.16% | −75,000−6.1% | Reduced |
| Northern Trust Corp | 1,186,211 | $17.7M | 0.00% | +184,801+18.5% | Added |
| Capital Research Global Investors | 1,199,545 | $17.8M | 0.00% | −133,247−10.0% | Reduced |
| BNP Paribas Arbitrage, SA | 1,224,422 | $18.2M | 0.01% | −319,916−20.7% | Reduced |
| ARS Investment Partners, LLC | 1,374,185 | $20.4M | 0.89% | −4,643−0.3% | Reduced |
| Price T Rowe Associates Inc | 1,456,851 | $21.7M | 0.00% | −760,324−34.3% | Reduced |
| Bank of America Corp | 1,477,838 | $22.0M | 0.00% | +718,413+94.6% | Added |
| Vanguard Capital Management LLC | 1,488,809 | $22.2M | 0.00% | +218,920+17.2% | Added |
| Citadel Advisors LLC | 1,619,676 | $24.1M | 0.01% | −103,431−6.0% | Reduced |
| Rubric Capital Management LP | 1,721,493 | $25.6M | 0.23% | +1,721,493 | New |
| Nuveen, LLC | 1,744,334 | $26.0M | 0.01% | +998,586+133.9% | Added |
| TCG Crossover Management, LLC | 1,779,952 | $26.5M | 0.64% | −2,851,365−61.6% | Reduced |
| Balyasny Asset Management LLC | 1,879,734 | $28.0M | 0.05% | −565,682−23.1% | Reduced |
| Knoll Capital Management, LLC | 2,352,520 | $35.0M | 16.78% | +23,918+1.0% | Added |
| Vanguard Portfolio Management LLC | 2,488,941 | $37.0M | 0.00% | +209,666+9.2% | Added |
| UBS Group AG | 2,518,827 | $37.5M | 0.01% | +1,092,400+76.6% | Added |
| Goldman Sachs Group Inc | 2,583,046 | $38.4M | 0.00% | +69,865+2.8% | Added |
| Cormorant Asset Management, LP | 2,610,000 | $38.8M | 1.99% | +850,000+48.3% | Added |
| Royalty Pharma Sub-Manager, LLC | 2,936,507 | $43.7M | 18.06% | 00.0% | Unchanged |
| FMR LLC | 2,964,630 | $44.1M | 0.00% | +605,583+25.7% | Added |
| Geode Capital Management, LLC | 3,323,190 | $49.5M | 0.00% | +555,427+20.1% | Added |
| AQR Capital Management LLC | 4,150,616 | $61.8M | 0.02% | +2,175,100+110.1% | Added |
| D. E. Shaw & Co., Inc. | 4,190,195 | $62.4M | 0.04% | +1,343,002+47.2% | Added |
| Infinitum Asset Management, LLC | 6,250,000 | $93.0M | 9.46% | 00.0% | Unchanged |
| State Street Corp | 6,947,034 | $103.4M | 0.00% | +328,231+5.0% | Added |
| Woodline Partners LP | 7,660,280 | $114.0M | 0.35% | +7,359,891+2,450.1% | Added |
| Jupiter Topco LLC | 8,584,675 | $127.9M | 0.05% | +8,584,675 | New |
| Stifel Financial Corp | 9,941,165 | $147.9M | 0.12% | +2800.0% | Added |
| Suvretta Capital Management, LLC | 10,286,937 | $153.1M | 3.22% | 00.0% | Unchanged |
| BlackRock, Inc. | 13,210,585 | $196.6M | 0.00% | +1,988,178+17.7% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −1,501,099−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −1,163,926−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −702,884−100.0% | Sold out |